FDA.reportPublic FDA data

nintedanib 150 MG Oral Capsule

RxCUI
1592750
RxNorm name
nintedanib 150 MG Oral Capsule
Display name
nintedanib 150 MG Oral Capsule
Full name
nintedanib 150 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Nintedanib esylateNINTEDANIB ESYLATEMacleods Pharmaceuticals Limited9925b305-c1fb-43b6-a5fd-e03f14f28e6c2026-08-03Warnings, Adverse reactionsExact identifier
rxcui: 1592750
NintedanibNINTEDANIBGolden State Medical Supply, Inc.4ecf7f05-4a95-b98c-e063-6394a90ab8962026-07-30Warnings, Adverse reactionsExact identifier
rxcui: 1592750
NintedanibNINTEDANIBEdenbridge Pharmaceuticals LLC.43dae004-eaf6-4411-8c3d-db7ab2c3b41e2026-07-29Warnings, Adverse reactionsExact identifier
rxcui: 1592750
nintedanibNINTEDANIBAvKARE572722d7-338a-e4d2-e063-6394a90a257c2026-07-21Warnings, Adverse reactionsExact identifier
rxcui: 1592750
nintedanibNINTEDANIBGlenmark Pharmaceuticals Inc., USAb14164fb-0276-4ad1-a5ff-400ab9e292da2026-07-10Warnings, Adverse reactionsExact identifier
rxcui: 1592750
nintedanibNINTEDANIBEPIC PHARMA LLC0e12f080-fcb4-465f-b988-4fa2c79f49aa2026-07-09Warnings, Adverse reactionsExact identifier
rxcui: 1592750
Nintedanib Capsules, 100 mg and 150 mgNINTEDANIBEXELAN PHARMACEUTICALS INC.60d8104e-cb6c-4f4f-8159-95ed57346ffa2026-04-21Warnings, Adverse reactionsExact identifier
rxcui: 1592750
NintedanibNINTEDANIBCipla USA Inc.4d017c42-a823-452d-bc6f-0491dd9823e32026-04-02Warnings, Adverse reactionsExact identifier
rxcui: 1592750
NintedanibNINTEDANIBApotex Corp.b72b26c3-7731-80c0-734b-a5f53a1d89ae2026-03-20Warnings, Adverse reactionsExact identifier
rxcui: 1592750
nintedanibNINTEDANIBSandoz Inc751c3473-35d6-47d6-b405-af16a989716c2026-01-20Warnings, Adverse reactionsExact identifier
rxcui: 1592750
NintedanibNINTEDANIBDr. Reddy's Laboratories Inc.88f8600d-0974-51ca-6f8e-28c48a379e082025-11-20Warnings, Adverse reactionsExact identifier
rxcui: 1592750
OfevNINTEDANIBBoehringer Ingelheim Pharmaceuticals, Inc.da1c9f37-779e-4682-816f-93d0faa4cfc92025-11-20Warnings, Adverse reactionsExact identifier
rxcui: 1592750

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
da1c9f37-779e-4682-816f-93d0faa4cfc9nintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]321These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 201420251120
88f8600d-0974-51ca-6f8e-28c48a379e08nintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]34These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 201420251120
4d017c42-a823-452d-bc6f-0491dd9823e3nintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]33These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 201420260402
43dae004-eaf6-4411-8c3d-db7ab2c3b41enintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]32These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 201420260415
751c3473-35d6-47d6-b405-af16a989716cnintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]32These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 201420260120
60d8104e-cb6c-4f4f-8159-95ed57346ffanintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]31These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 201420260421
4ecf7f05-4a95-b98c-e063-6394a90ab896nintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]31NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 201420260406
b72b26c3-7731-80c0-734b-a5f53a1d89aenintedanib 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [SCD] · nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]31These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 201420260320